We and others have previously identified DUSP4 as a critical regulator of Ras/MAPK activity and cancer stem cell-like functionality in breast cancer, most notably in basal-like breast cancers (BLBC) [2–4, 13], a molecular breast cancer subtype correlating with clinically defined triple negative breast cancers (TNBCs). The gene discussed is DUSP4; the disease is breast cancer.